| 5YU9: reference: Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation., Wang A, Yan XE, Wu H, Wang W, Hu C, Chen C, Zhao Z, Zhao P, Li X, Wang L, Wang B, Ye Z, Wang J, Wang C, Zhang W, Gray NS, Weisberg EL, Chen L, Liu J, Yun CH, Liu Q, Oncotarget. 2016 Oct 25;7(43):69760-69769. doi: 10.18632/oncotarget.11951. PMID: 27626175 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).